|
시장보고서
상품코드
1762311
세계의 반려동물용 백신 시장, 규모, 점유율, 동향, 산업 분석 보고서 : 투여 경로별, 제품 유형별, 동물 유형별, 유통 채널별, 지역별, 예측(2025-2034년)Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, By Region - Market Forecast, 2025-2034 |
||||||
Polaris Market Research의 최신 조사에 따르면 반려동물 백신 시장 규모는 2034년까지 85억 656만 달러에 달할 것으로 예측됩니다. 이 보고서는 현재 시장 역학에 대한 자세한 통찰력과 향후 시장 성장에 대한 분석을 제공합니다.
반려동물 백신 시장은 개, 고양이와 같은 가축 이외의 반려동물을 다양한 감염성 질환으로부터 보호하기 위해 개발된 생물학적 제제로 구성되어 있습니다. 이 시장은 반려동물의 인간화가 진행되고 반려동물 보호자들이 예방적 건강관리를 점점 더 중요하게 생각함에 따라 계속 진화하고 있습니다. 동물 면역학의 발전과 인수공통전염병의 위험에 대한 인식이 높아지면서 핵심 백신과 비핵심 백신 모두에 대한 수요가 증가하고 있습니다. 업계에서는 컴플라이언스 및 안전성을 높이기 위해 혼합백신, 무침 주사기 및 경구용 제형과 같은 새로운 전달 플랫폼의 채택이 증가하고 있습니다. 또한, 반려동물의 바이러스 및 세균 감염이 증가함에 따라 백신 개발, 특히 재조합 및 DNA 기반 기술의 혁신이 가속화되고 있습니다.
시장 성장은 반려동물 보험 적용 범위 확대와 동물 의료비 증가로 인해 가속화되고 있으며, 이는 총체적으로 백신의 보급을 촉진하고 있습니다. 시장 개척 기업들은 진화하는 병원체 프로파일과 항원 변이성에 대응하여 장시간 작용, 교차 방어, 균주 특이적 백신을 개발하기 위해 연구개발에 투자하고 있습니다. 엄격한 규제 감독을 통해 제품의 유효성과 안전성을 보장하기 위해 제조업체는 고도의 품질 보증을 실천하고 있습니다. 맞춤형 동물 의료와 백신 개발 파이프라인에 인공지능(AI)을 적용하는 것은 시장 출시 시간을 단축하고 타겟팅 정확도를 향상시킬 수 있는 좋은 기회입니다. 백신 인지도 향상에 있어 동물병원과 디지털 헬스 플랫폼의 역할 증가는 제약회사와 동물병원의 협력 관계 증가와 함께 시장 확대의 호재를 시사하고 있습니다.
반려동물용 백신 시장 보고서의 주요 내용
제품별로는 2024년 약독성 생백신 분야가 강력한 면역원성과 빠른 방어 개시 능력으로 가장 큰 점유율을 차지했습니다.
동물 유형별로는 고양이 백혈병 바이러스(FeLV) 및 고양이 면역 결핍 바이러스(FIV)와 같은 고양이 특유의 병원체에 대한 인식이 높아짐에 따라 고양이 부문이 예측 기간 동안 가장 높은 CAGR을 보일 것으로 예측됩니다.
2024년 북미 반려동물 백신 시장은 엄격한 반려동물 백신 접종법, 높은 수의학 서비스 이용률, 강력한 제약 R&D의 존재로 인해 북미 반려동물 백신 시장이 가장 큰 점유율을 차지했습니다.
아시아태평양 반려동물 백신 시장은 특히 중국, 인도, 동남아시아 등 신흥국의 반려동물 수가 빠르게 증가함에 따라 예측 기간 동안 가장 높은 CAGR을 나타낼 것으로 예측됩니다.
세계 주요 시장 기업으로는 Zoetis,Zoetis,Merck & Co., Inc. Bimeda Biologicals, Neogen Corporation 등이 있습니다.
목차
제1장 서론
제2장 주요 요약
제3장 조사 방법
제4장 반려동물용 백신 시장 인사이트
- 시장 현황
- 반려동물용 백신 시장 역학
- 성장 촉진요인과 기회
- 성장 억제요인과 과제
- PESTEL 분석
- 반려동물용 백신 시장 파워 평가 동향
- 밸류체인 분석
제5장 반려동물용 백신 시장 : 제품별
- 주요 조사 결과
- 서론
- 약독화 생백신
- 불활화 백신
- 아단위 백신
- DNA 백신
- 재조합 백신
제6장 반려동물용 백신 시장 : 투여 경로별
- 주요 조사 결과
- 서론
- 피하
- 근육내
- 비강내
제7장 반려동물용 백신 시장 : 동물 유형별
- 주요 조사 결과
- 서론
- 개
- 고양이
- 기타
제8장 반려동물용 백신 시장 : 유통 채널별
- 주요 조사 결과
- 서론
- 소매
- E-Commerce
- 병원 및 클리닉 약국
제9장 반려동물용 백신 시장 : 지역별
- 주요 조사 결과
- 서론
- 반려동물용 백신 시장 분석 : 지역별, 2020년-2034년
- 북미
- 북미 : 제품별, 2020-2034년
- 북미 : 투여 경로별, 2020-2034년
- 북미 : 유통 채널별, 2020-2034년
- 북미 : 동물 유형별, 2020-2034년
- 미국
- 캐나다
- 유럽
- 유럽 : 제품별, 2020-2034년
- 유럽 : 투여 경로별, 2020-2034년
- 유럽 : 유통 채널별, 2020-2034년
- 유럽 : 동물 유형별, 2020-2034년
- 영국
- 프랑스
- 독일
- 이탈리아
- 스페인
- 네덜란드
- 러시아
- 기타 유럽
- 아시아태평양
- 아시아태평양 : 제품별, 2020-2034년
- 아시아태평양 : 투여 경로별, 2020-2034년
- 아시아태평양 : 유통 채널별, 2020-2034년
- 아시아태평양 : 동물 유형별, 2020-2034년
- 중국
- 인도
- 말레이시아
- 일본
- 인도네시아
- 한국
- 호주
- 기타 아시아태평양
- 중동 및 아프리카
- 중동 및 아프리카 : 제품별, 2020-2034년
- 중동 및 아프리카 : 투여 경로별, 2020-2034년
- 중동 및 아프리카 : 유통 채널별, 2020-2034년
- 중동 및 아프리카 : 동물 유형별, 2020-2034년
- 사우디아라비아
- 아랍에미리트(UAE)
- 이스라엘
- 남아프리카공화국
- 기타 중동 및 아프리카
- 라틴아메리카
- 라틴아메리카 : 제품별, 2020-2034년
- 라틴아메리카 : 투여 경로별, 2020-2034년
- 라틴아메리카 : 유통 채널별, 2020-2034년
- 라틴아메리카 : 동물 유형별, 2020-2034년
- 멕시코
- 브라질
- 아르헨티나
- 기타 라틴아메리카
제10장 경쟁 구도
- 확대와 인수 분석
- 확대
- 인수
- 제휴/협업/합의/공개
제11장 기업 개요
- Bimeda Biologicals
- Boehringer Ingelheim Animal Health
- Calier
- Ceva
- Elanco
- Merck & Co., Inc.
- Neogen Corporation
- Phibro Animal Health Corporation
- Virbac
- Zoetis
The companion animal vaccines market size is expected to reach USD 8,506.56 million by 2034, according to a new study by Polaris Market Research. The report "Companion Animal Vaccines Market Size, Share, Trends, & Industry Analysis Report: By Route of Administration (Subcutaneous, Intramuscular, and Intranasal), By Product, By Animal Type, By Distribution Channel, and By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.
The companion animal vaccines market comprises biologic products developed to protect domestic pets such as dogs, cats, and other non-livestock animals from various infectious diseases. This market continues to evolve as pet humanization intensifies and pet owners increasingly prioritize preventative healthcare. Advancements in veterinary immunology, coupled with rising awareness of zoonotic disease risks, are driving robust demand for both core and non-core vaccines. The industry is witnessing increased adoption of combination vaccines and novel delivery platforms, such as needle-free injectors and oral formulations, enhancing compliance and safety. Rising incidences of viral and bacterial infections in household animals have also catalyzed innovation in vaccine development, particularly in recombinant and DNA-based technologies.
The market growth is accelerated by the expansion of pet insurance coverage and greater veterinary healthcare expenditure, which collectively support higher vaccine uptake. Market players are investing in R&D to develop long-acting, cross-protective, and strain-specific vaccines, responding to evolving pathogen profiles and antigenic variability. Stringent regulatory oversight ensures product efficacy and safety, prompting manufacturers to integrate advanced quality assurance practices. Opportunities lie in personalized veterinary medicine and the application of artificial intelligence (AI) in vaccine development pipelines, which shorten time-to-market and improve targeting accuracy. The increasing role of veterinary clinics and digital health platforms in raising vaccine awareness, coupled with growing collaboration between pharmaceutical firms and veterinary institutions, signals a favorable outlook for market expansion.
Companion Animal Vaccines Market Report Highlights
By product, in 2024, the attenuated live vaccines segment held the largest share due to their robust immunogenicity and rapid onset of protection.
Based on animal type, the feline segment is expected to witness the highest CAGR during the forecast period due to increasing awareness around feline-specific pathogens such as feline leukemia virus (FeLV) and feline immunodeficiency virus (FIV).
In 2024, the North America companion animal vaccines market held the largest share due to the region's stringent pet vaccination laws, high veterinary service utilization, and strong pharmaceutical R&D presence.
The Asia Pacific companion animal vaccines market is projected to register the highest CAGR during the forecast period, driven by a rapidly growing pet population, particularly in emerging economies such as China, India, and Southeast Asia.
A few global key market players include Zoetis; Merck & Co., Inc.; Boehringer Ingelheim Animal Health; Elanco; Virbac; Phibro Animal Health Corporation; Calier; Ceva; Bimeda Biologicals; and Neogen Corporation.
Polaris Market Research has segmented the market report on the basis of product, route of administration, animal type, distribution channel, and region:
By Product Outlook (Revenue, USD Million, 2020-2034)
Attenuated Live Vaccines
Inactivated Vaccines
Subunit Vaccines
DNA Vaccines
Recombinant Vaccines
By Route of Administration Outlook (Revenue, USD Million, 2020-2034)
Subcutaneous
Intramuscular
Intranasal
By Animal Type Outlook (Revenue, USD Million, 2020-2034)
Canine
Feline
Others
By Distribution Channel Outlook (Revenue, USD Million, 2020-2034)
Retail
E-Commerce
Hospital/Clinic Pharmacy
By Regional Outlook (Revenue, USD Million, 2020-2034)
North America
US
Canada
Europe
Germany
UK
France
Italy
Spain
Russia
Netherlands
Rest of Europe
Asia Pacific
China
India
Japan
South Korea
Indonesia
Malaysia
Vietnam
Australia
Rest of Asia Pacific
Latin America
Argentina
Brazil
Mexico
Rest of Latin America
Middle East & Africa
UAE
Saudi Arabia
Israel
South Africa
Rest of Middle East & Africa
Table of Contents
1. Introduction
- 1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
- 1.2. Stakeholders
2. Executive Summary
- 2.1. Market Highlights
3. Research Methodology
- 3.1. Overview
- 3.1.1. Data Mining
- 3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources
4. Companion Animal Vaccines Market Insights
- 4.1. Companion Animal Vaccines Market - Market Snapshot
- 4.2. Companion Animal Vaccines Market Dynamics
- 4.2.1. Drivers and Opportunities
- 4.2.1.1. Increasing Pet Ownership and Humanization of Pets
- 4.2.1.2. Growing Awareness About Zoonotic Diseases
- 4.2.2. Restraints and Challenges
- 4.2.2.1. High Costs
- 4.2.1. Drivers and Opportunities
- 4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
- 4.4. PESTEL Analysis
- 4.5. Companion Animal Vaccines Market Power Rating Trends
- 4.6. Value Chain Analysis
5. Companion Animal Vaccines Market, by Product
- 5.1. Key Findings
- 5.2. Introduction
- 5.2.1. Companion Animal Vaccines Market, by Product, 2020-2034 (USD Million)
- 5.3. Attenuated Live Vaccines
- 5.3.1. Companion Animal Vaccines Market, by Attenuated Live Vaccines, by Region, 2020-2034 (USD Million)
- 5.4. Inactivated Vaccines
- 5.4.1. Companion Animal Vaccines Market, by Inactivated Vaccines, by Region, 2020-2034 (USD Million)
- 5.5. Subunit Vaccines
- 5.5.1. Companion Animal Vaccines Market, by Subunit Vaccines, by Region, 2020-2034 (USD Million)
- 5.6. DNA Vaccines
- 5.6.1. Companion Animal Vaccines Market, by DNA Vaccines, by Region, 2020-2034 (USD Million)
- 5.7. Recombinant Vaccines
- 5.7.1. Companion Animal Vaccines Market, by Recombinant Vaccines, by Region, 2020-2034 (USD Million)
6. Companion Animal Vaccines Market, by Route of Administration
- 6.1. Key Findings
- 6.2. Introduction
- 6.2.1. Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 6.3. Subcutaneous
- 6.3.1. Companion Animal Vaccines Market, by Subcutaneous, by Region, 2020-2034 (USD Million)
- 6.4. Intramuscular
- 6.4.1. Companion Animal Vaccines Market, by Intramuscular, by Region, 2020-2034 (USD Million)
- 6.5. Intranasal
- 6.5.1. Companion Animal Vaccines Market, by Intranasal, by Region, 2020-2034 (USD Million)
7. Companion Animal Vaccines Market, by Animal Type
- 7.1. Key Findings
- 7.2. Introduction
- 7.2.1. Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 7.3. Canine
- 7.3.1. Companion Animal Vaccines Market, by Canine, by Region, 2020-2034 (USD Million)
- 7.4. Feline
- 7.4.1. Companion Animal Vaccines Market, by Feline, by Region, 2020-2034 (USD Million)
- 7.5. Other
- 7.5.1. Companion Animal Vaccines Market, by Other, by Region, 2020-2034 (USD Million)
8. Companion Animal Vaccines Market, by Distribution Channel
- 8.1. Key Findings
- 8.2. Introduction
- 8.2.1. Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 8.3. Retail
- 8.3.1. Companion Animal Vaccines Market, by Retail, by Region, 2020-2034 (USD Million)
- 8.4. E-Commerce
- 8.4.1. Companion Animal Vaccines Market, by E-Commerce, by Region, 2020-2034 (USD Million)
- 8.5. Hospital/ Clinic Pharmacy
- 8.5.1. Companion Animal Vaccines Market, by Hospital/ Clinic Pharmacy, by Region, 2020-2034 (USD Million)
9. Companion Animal Vaccines Market, by Geography
- 9.1. Key Findings
- 9.2. Introduction
- 9.2.1. Companion Animal Vaccines Market Assessment, By Geography, 2020-2034 (USD Million)
- 9.3. Companion Animal Vaccines Market - North America
- 9.3.1. North America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.2. North America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.3. North America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.4. North America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.5. Companion Animal Vaccines Market - US
- 9.3.5.1. US: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.5.2. US: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.5.3. US: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.5.4. US: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.3.6. Companion Animal Vaccines Market - Canada
- 9.3.6.1. Canada: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.3.6.2. Canada: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.3.6.3. Canada: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.3.6.4. Canada: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4. Companion Animal Vaccines Market - Europe
- 9.4.1. Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.2. Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.3. Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.4. Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.5. Companion Animal Vaccines Market - UK
- 9.4.5.1. UK: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.5.2. UK: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.5.3. UK: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.5.4. UK: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.6. Companion Animal Vaccines Market - France
- 9.4.6.1. France: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.6.2. France: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.6.3. France: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.6.4. France: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.7. Companion Animal Vaccines Market - Germany
- 9.4.7.1. Germany: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.7.2. Germany: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.7.3. Germany: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.7.4. Germany: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.8. Companion Animal Vaccines Market - Italy
- 9.4.8.1. Italy: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.8.2. Italy: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.8.3. Italy: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.8.4. Italy: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.9. Companion Animal Vaccines Market - Spain
- 9.4.9.1. Spain: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.9.2. Spain: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.9.3. Spain: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.9.4. Spain: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.10. Companion Animal Vaccines Market - Netherlands
- 9.4.10.1. Netherlands: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.10.2. Netherlands: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.10.3. Netherlands: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.10.4. Netherlands: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.11. Companion Animal Vaccines Market - Russia
- 9.4.11.1. Russia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.11.2. Russia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.11.3. Russia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.11.4. Russia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.4.12. Companion Animal Vaccines Market - Rest of Europe
- 9.4.12.1. Rest of Europe: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.4.12.2. Rest of Europe: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.4.12.3. Rest of Europe: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.4.12.4. Rest of Europe: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5. Companion Animal Vaccines Market - Asia Pacific
- 9.5.1. Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.2. Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.3. Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.4. Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.5. Companion Animal Vaccines Market - China
- 9.5.5.1. China: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.5.2. China: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.5.3. China: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.5.4. China: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.6. Companion Animal Vaccines Market - India
- 9.5.6.1. India: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.6.2. India: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.6.3. India: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.6.4. India: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.7. Companion Animal Vaccines Market - Malaysia
- 9.5.7.1. Malaysia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.7.2. Malaysia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.7.3. Malaysia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.7.4. Malaysia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.8. Companion Animal Vaccines Market - Japan
- 9.5.8.1. Japan: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.8.2. Japan: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.8.3. Japan: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.8.4. Japan: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.9. Companion Animal Vaccines Market - Indonesia
- 9.5.9.1. Indonesia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.9.2. Indonesia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.9.3. Indonesia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.9.4. Indonesia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.10. Companion Animal Vaccines Market - South Korea
- 9.5.10.1. South Korea: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.10.2. South Korea: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.10.3. South Korea: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.10.4. South Korea: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.11. Companion Animal Vaccines Market - Australia
- 9.5.11.1. Australia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.11.2. Australia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.11.3. Australia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.11.4. Australia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.5.12. Companion Animal Vaccines Market - Rest of Asia Pacific
- 9.5.12.1. Rest of Asia Pacific: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.5.12.2. Rest of Asia Pacific: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.5.12.3. Rest of Asia Pacific: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.5.12.4. Rest of Asia Pacific: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6. Companion Animal Vaccines Market - Middle East & Africa
- 9.6.1. Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.2. Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.3. Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.4. Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.5. Companion Animal Vaccines Market - Saudi Arabia
- 9.6.5.1. Saudi Arabia: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.5.2. Saudi Arabia: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.5.3. Saudi Arabia: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.5.4. Saudi Arabia: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.6. Companion Animal Vaccines Market - UAE
- 9.6.6.1. UAE: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.6.2. UAE: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.6.3. UAE: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.6.4. UAE: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.7. Companion Animal Vaccines Market - Israel
- 9.6.7.1. Israel: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.7.2. Israel: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.7.3. Israel: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.7.4. Israel: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.8. Companion Animal Vaccines Market - South Africa
- 9.6.8.1. South Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.8.2. South Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.8.3. South Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.8.4. South Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.6.9. Companion Animal Vaccines Market - Rest of Middle East & Africa
- 9.6.9.1. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.6.9.2. Rest of Middle East & Africa: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.6.9.3. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.6.9.4. Rest of Middle East & Africa: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7. Companion Animal Vaccines Market - Latin America
- 9.7.1. Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.2. Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.3. Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.4. Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.5. Companion Animal Vaccines Market - Mexico
- 9.7.5.1. Mexico: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.5.2. Mexico: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.5.3. Mexico: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.5.4. Mexico: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.6. Companion Animal Vaccines Market - Brazil
- 9.7.6.1. Brazil: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.6.2. Brazil: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.6.3. Brazil: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.6.4. Brazil: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.7. Companion Animal Vaccines Market - Argentina
- 9.7.7.1. Argentina: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.7.2. Argentina: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.7.3. Argentina: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.7.4. Argentina: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
- 9.7.8. Companion Animal Vaccines Market - Rest of Latin America
- 9.7.8.1. Rest of Latin America: Companion Animal Vaccines Market, By Product, 2020-2034 (USD Million)
- 9.7.8.2. Rest of Latin America: Companion Animal Vaccines Market, By Route of Administration, 2020-2034 (USD Million)
- 9.7.8.3. Rest of Latin America: Companion Animal Vaccines Market, by Distribution Channel, 2020-2034 (USD Million)
- 9.7.8.4. Rest of Latin America: Companion Animal Vaccines Market, by Animal Type, 2020-2034 (USD Million)
10. Competitive Landscape
- 10.1. Expansion and Acquisition Analysis
- 10.1.1. Expansion
- 10.1.2. Acquisitions
- 10.2. Partnerships/Collaborations/Agreements/Exhibitions
11. Company Profiles
- 11.1. Bimeda Biologicals
- 11.1.1. Company Overview
- 11.1.2. Financial Performance
- 11.1.3. Product Benchmarking
- 11.1.4. Recent Development
- 11.2. Boehringer Ingelheim Animal Health
- 11.2.1. Company Overview
- 11.2.2. Financial Performance
- 11.2.3. Product Benchmarking
- 11.2.4. Recent Development
- 11.3. Calier
- 11.3.1. Company Overview
- 11.3.2. Financial Performance
- 11.3.3. Product Benchmarking
- 11.3.4. Recent Development
- 11.4. Ceva
- 11.4.1. Company Overview
- 11.4.2. Financial Performance
- 11.4.3. Product Benchmarking
- 11.4.4. Recent Development
- 11.5. Elanco
- 11.5.1. Company Overview
- 11.5.2. Financial Performance
- 11.5.3. Product Benchmarking
- 11.5.4. Recent Development
- 11.6. Merck & Co., Inc.
- 11.6.1. Company Overview
- 11.6.2. Financial Performance
- 11.6.3. Product Benchmarking
- 11.6.4. Recent Development
- 11.7. Neogen Corporation
- 11.7.1. Company Overview
- 11.7.2. Financial Performance
- 11.7.3. Product Benchmarking
- 11.7.4. Recent Development
- 11.8. Phibro Animal Health Corporation
- 11.8.1. Company Overview
- 11.8.2. Financial Performance
- 11.8.3. Product Benchmarking
- 11.8.4. Recent Development
- 11.9. Virbac
- 11.9.1. Company Overview
- 11.9.2. Financial Performance
- 11.9.3. Product Benchmarking
- 11.9.4. Recent Development
- 11.10. Zoetis
- 11.10.1. Company Overview
- 11.10.2. Financial Performance
- 11.10.3. Product Benchmarking
- 11.10.4. Recent Development
